Competition and Antitrust
Pogust Goodhead continues to fight for individuals who have been injured by the iron deficiency anemia drug, Injectafer.
Injectafer was brought to the...
On 5 January 2022, the Paris Judicial Tribunal (Tribunal Judiciaire de Paris)[1] ruled for the first time since group actions were introduced into French...
